KPC PHARMACEUTICALS,INC KPC Pharmaceuticals,Inc reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 3,633.22 million compared to CNY 3,715.99 million a year ago. Revenue was CNY 3,770.64 million compared to CNY 4,227.51 million a year ago.
Net income was CNY 223.37 million compared to CNY 216.6 million a year ago. Basic earnings per share from continuing operations was CNY 0.29 compared to CNY 0.29 a year ago. Diluted earnings per share from continuing operations was CNY 0.29 compared to CNY 0.29 a year ago.
